Neoadjuvant chemotherapy vs, radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): Preliminary results of randomized phase II trial

被引：6
|
作者：
Pereira, JR
Martins, SJ
Ikari, FK
Nikaedo, SM
Gampel, O
机构：
[1] Arnaldo Vieira Carvalho Canc Inst, Sao Paulo, Brazil
[2] Paulista Lung Canc Treatment Grp, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81452-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1032
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [31] PRELIMINARY RESULTS OF A PHASE II STUDY OF METRONOMIC CHEMOTHERAPY (MC) WITH BEVACIZUMAB (B) IN ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC)
    Robert, Francisco
    Womack, Mark
    Deshazo, Mollie
    Cantor, Alan
    Jerome, Mary
    Miley, Debi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S551 - S551
  • [32] Randomized phase 2 study of radiotherapy alone versus radiotherapy with paclitaxel in non-small cell lung cancer
    Sarihan, S
    Kayisogullari, U
    Ercan, I
    Engin, K
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (04) : 375 - 383
  • [33] Randomized phase II trial of NGR-hTNF in combination with standard chemotherapy in previously untreated non-small cell lung cancer (NSCLC).
    Gregorc, Vanesa
    Zilembo, Nicoletta
    Grossi, Francesco
    De Pas, Tommaso M.
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Citterio, Giovanni
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy: preliminary results
    Ross, HJ
    Blumenschein, GR
    Dowlati, A
    Aisner, J
    Rigas, JR
    Stanislaus, M
    Leopold, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 645S - 645S
  • [35] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Neoadjuvant Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Nakagawa, Taku
    Minamiya, Yoshihiro
    Saito, Hajime
    Imai, Kazuhiro
    Konno, Hayato
    Kudo, Satoshi
    Saito, Yoshitaro
    Kurihara, Nobuyasu
    Watanabe, Shinnosuke
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S686
  • [37] Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer
    Abratt, Raymond P.
    Lee, Jung Sin
    Han, Ji Youn
    Tsai, Chun-Ming
    Boyer, Michael
    Mok, Ton
    Kim, Sang-We
    Lee, Jin Soo
    Brnabic, Alan J. M.
    Reece, William H. H.
    Lehnert, Manfred
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 135 - 140
  • [38] Randomized phase II study of gefitinib alone or with simvastatin in previously treated advanced non-small cell lung cancer (NSCLC)
    Han, J.
    Lee, S.
    Yun, T.
    Moon, Y.
    Park, I.
    Kim, H.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Combination therapy of envafolimab and suvemcitug with chemotherapy in patients with non-small cell lung cancer (NSCLC): Results from a phase II clinical trial
    Wu, C.
    Wu, L.
    Meng, X.
    Wang, Y.
    Fan, Q.
    Wang, X.
    Gu, K.
    Ma, R.
    Hu, C.
    Lu, L.
    Su, F.
    Yang, C.
    Liu, Z.
    Tian, J.
    Sun, X.
    Sun, S.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2023, 34
  • [40] Final results of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomized study by the European Lung Cancer Working Party
    Berghmans, T.
    Lafitte, J.
    Giner, V.
    Berchier, M.
    Scherpereel, A.
    Paesmans, M.
    Meert, A.
    Bosschaerts, T.
    Leclercq, N.
    Sculier, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345